Vivani Medical VANI
NASDAQ VANI
$1.25 -0.07 (-4.94%)
At close: Sep 10, 2026 · 4:00 PM EDT

Vivani Medical (VANI) Net Shares Issued and Repurchased (2014 - 2026)

Vivani Medical (VANI) posted Net Shares Issued and Repurchased of $227.0 for Q1 2026, down 99.99% on a QoQ basis from $1.9 million in Q4 2025, and down 99.91% year-over-year from $256215.0 in Q1 2025.

Analysis

Vivani Medical (VANI) Net Shares Issued and Repurchased (2014 - 2026) Analysis & Trends

Vivani Medical has reported Net Shares Issued and Repurchased for 13 years, with the latest figure at $227.0 in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 99.91% year-over-year to $227.0 in Q1 2026; TTM through Mar 2026 was $227.0, a 99.91% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, up 72.1% from the prior year.
  • Net Shares Issued and Repurchased was $227.0 for Q1 2026 at Vivani Medical, down from $1.9 million in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $1.9 million in Q4 2025, with the low at $2.0 in Q1 2022.
  • Average Net Shares Issued and Repurchased over 5 years is $660217.6, with a median of $402500.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased sank 99.99% in 2022, then surged 20124900.0% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $866000.0 in 2022, then surged by 59.82% to $1.4 million in 2023, then declined by 21.03% to $1.1 million in 2024, then jumped by 72.1% to $1.9 million in 2025, then plunged by 99.99% to $227.0 in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $227.0 (Q1 2026), $1.9 million (Q4 2025), and $256215.0 (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn -
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -3.07 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Vivani Medical 109.30 Mn 89.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 227.00
Dec 31, 2025 1.88 Mn
Mar 31, 2025 256,215.00
Dec 31, 2024 1.09 Mn
Mar 31, 2024 59,014.00
Dec 31, 2023 1.38 Mn
Mar 31, 2023 402,500.00
Dec 31, 2022 866,000.00
Mar 31, 2022 2.00
Dec 31, 2021 875,000.00
Mar 31, 2021 14,000.00
Dec 31, 2020 1.02 Mn
Sep 30, 2020 71,000.00
Jun 30, 2020 586,000.00
Mar 31, 2020 300,000.00
Dec 31, 2019 336,000.00
Mar 31, 2019 2.10 Mn
Dec 31, 2018 397,000.00
Mar 31, 2018 2.34 Mn
Dec 31, 2017 2.70 Mn